JUXTAPID Trademark

Trademark Overview

On Friday, February 22, 2013, a trademark application was filed for JUXTAPID with the United States Patent and Trademark Office. The USPTO has given the JUXTAPID trademark a serial number of 85857475. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 14, 2015. This trademark is owned by Aegerion Pharmaceuticals, Inc.. The JUXTAPID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA
juxtapid

General Information

Serial Number85857475
Word MarkJUXTAPID
Filing DateFriday, February 22, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 14, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "JUXTAPID" on the left side are three stylized, semi-transparent crescent-like symbols. The first crescent-like symbol arcs horizontally from the letter "t" to the letter "J". The second crescent-like symbol intersects the first crescent-like symbol above the "x" and arcs horizontally from the letter "x" to the "J" above the first crescent-like symbol. The third crescent-like symbol is shorter than the first and second crescent-like symbols and intersects the first crescent-like symbol at, and arcs above, the "t".
Goods and ServicesPHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 1, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAegerion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, September 14, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 14, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, March 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 5, 2015EXTENSION 3 GRANTED
Thursday, February 12, 2015EXTENSION 3 FILED
Thursday, February 12, 2015TEAS EXTENSION RECEIVED
Wednesday, August 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 19, 2014EXTENSION 2 GRANTED
Wednesday, August 13, 2014EXTENSION 2 FILED
Wednesday, August 13, 2014TEAS EXTENSION RECEIVED
Saturday, February 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2014EXTENSION 1 GRANTED
Thursday, February 13, 2014EXTENSION 1 FILED
Thursday, February 13, 2014TEAS EXTENSION RECEIVED
Tuesday, February 4, 2014CORRECTED NOA E-MAILED
Monday, February 3, 2014DIVISIONAL PROCESSING COMPLETE
Tuesday, December 17, 2013DIVISIONAL REQUEST RECEIVED
Thursday, January 30, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 29, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 17, 2013TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 1, 2013ASSIGNED TO LIE
Saturday, April 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 9, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2013NON-FINAL ACTION E-MAILED
Tuesday, April 9, 2013NON-FINAL ACTION WRITTEN
Saturday, March 30, 2013ASSIGNED TO EXAMINER
Saturday, March 2, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 26, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

juxtapid disease particular hyperlipidemia cardiovascular field research development pharmaceutical